Skip to main content
Microbiology Spectrum logoLink to Microbiology Spectrum
. 2022 Oct 11;10(6):e02469-22. doi: 10.1128/spectrum.02469-22

Staphylococcal Corneocyte Adhesion: Assay Optimization and Roles of Aap and SasG Adhesins in the Establishment of Healthy Skin Colonization

Krista B Mills a, Paroma Roy b, Jakub M Kwiecinski a,c, Paul D Fey b, Alexander R Horswill a,d,
Editor: Catherine Ayn Brissettee
PMCID: PMC9769725  PMID: 36219106

ABSTRACT

Staphylococcus aureus is an opportunistic pathogen that causes the majority of wound and soft tissue infections. The accumulation-associated protein (Aap) from S. epidermidis and surface protein G (SasG) from S. aureus are cell wall-anchored (CWA) proteins known to be important in adhesion to healthy corneocytes from human skin. We investigated the mechanisms by which S. aureus colonizes healthy human skin by developing an optimized corneocyte adhesion assay. Trypan blue was used for enhanced red autofluorescent visualization of corneocytes with an overlay of green-fluorescent bacteria. The percent area of bacterial adhesion for images acquired by a fluorescence microscope was quantified using Fiji ImageJ. Using this optimized imaging procedure, differences in adhesion between various species and strains of staphylococci were measured. The ability of purified SasG to reduce Staphylococcus epidermidis adhesion was investigated in order to determine if these CWA proteins can compete for binding sites. To further test CWA-mediated adhesion, we engineered a nonadhering S. carnosus strain to express full-length SasG from two methicillin-resistant S. aureus (MRSA) strains. Finally, we demonstrated that the SasG A domain was a critical region of this surface protein for adherence to healthy human corneocytes. The developed imaging and expression methods are useful for studying staphylococcal adhesion to healthy human skin and have the potential to be used with a wide variety of fluorescently labeled organisms on both healthy and disease-state (such as atopic dermatitis) corneocytes.

IMPORTANCE The skin is the largest organ of the human body and acts as a shield against hazards such as harmful bacteria like Staphylococcus aureus. A diverse skin microbiota and immune cross talk control S. aureus numbers. S. aureus can bind to healthy skin and subsequently proliferate when the skin barrier is compromised, such as in a wound or in patients with atopic dermatitis (AD). It is important to understand these mechanisms in an effort to prevent pathogenic bacteria from causing infection. We describe an augmented corneocyte adhesion assay using fluorescence microscopy to study binding of various staphylococcal species to healthy human skin cells. In addition, we tested the ability of homologous proteins from different staphylococcal species to reduce binding, and developed a new S. carnosus expression system to test individual protein binding properties. Our newly developed methods and findings will enhance the understanding of how staphylococci bind to healthy human skin.

KEYWORDS: Staphylococcus, corneocytes, adhesion, fluorescence microscopy, accumulation-associated protein, Aap, surface protein G, SasG

INTRODUCTION

Staphylococcus aureus is a virulent, opportunistic pathogen that is a significant burden on hospital and community health (1). Skin adherence is a critical component of S. aureus pathogenesis, as transient skin colonization is thought to be a key step in the transition to infection (2). This Gram-positive pathogen is the cause of up to 76% of all recorded cases of skin and soft tissue infections (3, 4). S. aureus colonization is asymptomatic and transient, with approximately 30% of humans permanently colonized in the anterior nares (5, 6). In contrast, skin colonization occurs at rates of 5% or less (710). Epidermal homeostasis is maintained by environmental factors and commensal microbiota/immune system cross talk that control S. aureus numbers, contributing to the low colonization rate (7, 1116). It is important to study bacterial adhesion mechanisms and cross-interactions between different species on the skin and the reservoir nasal epithelia, considering that skin and soft tissue infections can lead to further metastatic infection (7, 16, 17).

The skin is the largest organ in the human body and acts as an essential barrier against S. aureus invasion and infection (18). The skin is composed of three layers: the epidermis as the outermost layer, the dermis, and the hypodermis as the innermost layer (19). The most superficial region of the epidermis is the stratum corneum (SC), which is formed by terminal differentiation of keratinocytes upward through the epidermal layers into corneocytes (denucleated keratinocytes with cornified envelopes in replacement of membranes) (18). As the outermost layer, the SC is the first site of contact for S. aureus, and attachment is a crucial prerequisite for infection. S. aureus utilizes an array of cell wall-anchored (CWA) proteins to mediate initial attachment to the skin, which is essential for colonization (5, 20, 21). Different CWA proteins are utilized depending on whether the skin is healthy or compromised. For example, clumping factor B (ClfB) has been demonstrated to be important for S. aureus adhesion to atopic dermatitis (AD) corneocytes (22). For healthy corneocytes, recent studies have indicated that S. aureus surface protein G (SasG) and the homologous protein in Staphylococcus epidermidis, accumulation-associated protein (Aap), are important for adhesion to both human skin and nasal corneocytes (2326).

Corneocyte adhesion assays have been characterized previously for use in studying adhesion of staphylococci to healthy animal and human corneocytes (25, 2730) and to corneocytes from the nose and AD skin (22, 26). This article builds and improves upon these previous works by describing an optimized corneocyte adhesion assay using fluorescence microscopy to provide enhanced qualitative and quantitative analysis of staphylococcal adhesion to healthy human corneocytes. Using this new method, the role of SasG in S. aureus adhesion to healthy human corneocytes was further explored. The ability of recombinant protein to block staphylococcal adhesion by blocking the ubiquitous colonizer S. epidermidis with SasG is demonstrated. Additionally, a Staphylococcus carnosus strain was engineered for heterologous protein expression to study the function of SasG-mediated adhesion. In S. epidermidis, Aap-mediated adhesion is dependent on the conserved L-type lectin subdomain within the N-terminal A domain (25), and as SasG is homologous to Aap, the importance of the A domain in SasG-mediated adhesion was explored. Collectively, this optimized assay and new tools were used to demonstrate an important role of SasG and Aap in S. aureus and S. epidermidis binding of human corneocytes and identify a key function for the A domain in these interactions.

RESULTS

Optimization of corneocyte staining.

In order to acquire images in which corneocytes fluoresced in a contrasting color against the green-fluorescing bacteria, a variety of methods and dyes were selected. Antibody staining with an anti-keratin 14 rabbit primary monoclonal antibody (Sigma-Aldrich) and Alexa Fluor 594 anti-rabbit IgG (Invitrogen) secondary antibody was attempted first (data not shown). This method did not result in clear images, and the images autofluoresced red, green, and blue when imaged with the respective color channels on the fluorescence microscope. A variety of dyes were then tested for either red or blue autofluorescence without autofluorescing green (data not shown). Three hundred microliters of the following dyes was incubated on corneocytes for 15 min at room temperature and imaged with the red, green, and blue channels on the fluorescence microscope: safranin, methyl green, Congo red, orange G, rhodamine B, fluorescein green, and trypan blue. Of these dyes, trypan blue (which stains dead cells) was the only dye that did not autofluoresce green and resulted in clear images with the red channel.

Autofluorescent staining of corneocytes with trypan blue and incubation with green fluorescent protein (GFP)-expressing bacteria was then optimized. Corneocyte collection and incubation with S. epidermidis Δica were performed as described in Materials and Methods (Fig. 1). Four conditions were tested on corneocytes: a bacteria-only control (Fig. 2A), incubation with bacteria followed by incubation with trypan blue (Fig. 2B), incubation with trypan blue for 15 min followed by incubation with bacteria (Fig. 2C), and mixing 300 μL of prepared bacterial culture and 300 μL of trypan blue and then incubating the entire mixture on corneocytes for 45 min (Fig. 2D). Incubating the corneocytes with bacteria first followed by trypan blue (Fig. 2B) resulted in the image that most closely resembled the bacteria-only control. Incubating corneocytes with trypan blue followed by bacteria resulted in lower bacterial numbers and less nonspecific binding than the bacteria-only control (Fig. 2C). Incubating corneocytes with a 600-μL total mixture of prepared bacterial culture and trypan blue also resulted in lower bacterial numbers than the bacteria-only control and some nonspecific binding (Fig. 2D). As a result, the corneocyte staining technique chosen was that depicted in Fig. 2B, as this technique did not result in a loss of bacterial numbers or nonspecific binding.

FIG 1.

FIG 1

Schematic of the corneocyte adhesion assay. (Step 1) Corneocytes are collected with tape stripping discs from the upper or lower arm near the elbow of a volunteer with healthy skin. (Step 2) Corneocytes can be preincubated with protein for 45 min or (step 3) incubated with fluorescent bacteria at an OD600 of 0.15 for 45 min. (Step 4) Corneocytes incubated with bacteria only are stained with trypan blue for 15 min. (Step 5) After incubation and/or staining, corneocytes are washed, mounted on a slide, and imaged with a fluorescence microscope. (Step 6) Bacterial images are quantified for percent area of adhesion with Fiji ImageJ.

FIG 2.

FIG 2

Optimization of corneocyte red autofluorescence with trypan blue. Corneocytes were incubated with (A) S. epidermidis Δica only, (B) bacteria first followed by trypan blue, (C) trypan blue first followed by bacteria, or (D) a mixture of 300 μL bacteria and 300 μL trypan blue at the same time.

Imaging and quantifying adhesion of staphylococci to corneocytes.

A variety of staphylococcal strains (Table 1) were tested for the ability to adhere to healthy human corneocytes. S. epidermidis Δica and S. epidermidis Δica Δaap have already been tested for adhesion to corneocytes by Roy et al. (25) and were used as controls. As shown by Roy et al. (25), polysaccharide intercellular adhesin (PIA) does not contribute to corneocyte adhesion, and therefore, the Δica strain was used as a wild-type (WT) background in this study. In support of these findings, S. epidermidis Δica Δaap exhibits significantly less adhesion to corneocytes than S. epidermidis Δica (Fig. 3A). S. aureus is infrequently isolated from healthy skin (9), and both USA300 methicillin-resistant S. aureus (MRSA) strain LAC and USA400 MRSA strain MW2 exhibited significantly less adhesion to corneocytes than S. epidermidis (Fig. 3A). Roy et al. (25) also observed that MW2 ΔmgrA exhibits significantly greater adhesion to corneocytes than MW2 WT, and we confirmed these findings (Fig. 3A).

TABLE 1.

Bacterial strains used in this studya

Strain Species Derivative strain Genotype Plasmid
AH2983 S. epidermidis 1457 Δica pCM29
AH2984 S. epidermidis 1457 Δica Δaap pCM29
AH3669 MRSA LAC (USA300) NA pCM29
AH4477 MRSA MW2 (USA400) NA pCM29
AH4478 MRSA MW2 (USA400) ΔmgrA pCM29
AH5037 S. hominis C5 NA pCM29
AH5687 S. carnosus TM300 ΔSCA_2238::sGFP ΔSCA_2092 NA
AH5905 S. carnosus TM300 ΔSCA_2238::sGFP ΔSCA_2092 pALC2073-sasGMW2
AH5907 S. carnosus TM300 ΔSCA_2238::sGFP ΔSCA_2092 pALC2073
AH5908 S. carnosus TM300 ΔSCA_2238::sGFP ΔSCA_2092 pALC2073-sasGCOL
AH6012 S. carnosus TM300 ΔSCA_2238::sGFP ΔSCA_2092 pHC109 (pALC2073-sasGMW2ΔA)
a

NA, not applicable.

FIG 3.

FIG 3

Adhesion of various staphylococci to corneocytes. Various staphylococcal species and strains were tested for adhesion to healthy human corneocytes: S. epidermidis Δica (AH2983), S. epidermidis Δica Δaap (AH2984), MRSA USA300 (AH3669), MRSA MW2 WT (AH4477), MRSA MW2 ΔmgrA (AH4478), S. hominis (AH5037), and S. carnosus (AH5687). (A) The percent area of adhesion in 10 images from three independent experiments (n = 30) was measured with Fiji ImageJ and analyzed in GraphPad Prism. Statistical significance was analyzed using the Kruskal-Wallis nonparametric test. Statistical significance of all groups except for MRSA MW2 ΔmgrA are mapped to S. epidermidis Δica (***, P = 0.0005; ****, P < 0.0001). Statistical significance of MRSA MW2 ΔmgrA is mapped to MRSA MW2 WT (***, P = 0.0001). (B) Representative green-channel, red-channel, and red- and green-channel overlay images of each species and strain tested in the corneocyte adhesion assay.

Staphylococcus hominis is one of the coagulase-negative staphylococci (CoNS) most frequently isolated from the skin (31) and, as expected, adheres to corneocytes similarly to S. epidermidis Δica (Fig. 3A). S. carnosus TM300 is an avirulent species that lacks many surface adhesins (32). In support of this, we observed that this species does not adhere to corneocytes (Fig. 3A). Representative green-channel, red-channel, and red- and green-channel overlay images of each strain in this assay can be seen in Fig. 3B.

Purified SasG blocks adhesion of S. epidermidis to corneocytes.

The ability of protein to block bacterial adhesion in our assay was then tested. Many strains of S. aureus express a protein homologous to Aap called SasG (2426). We had previously purified and characterized full-length recombinant SasG (33). While the host ligands of Aap and SasG have yet to be elucidated, these surface proteins share up to 95% sequence identity in the A domain (25), suggesting that they may bind to the same host ligand and compete with other staphylococci that possess homologous proteins. The ability of purified SasG to inhibit adhesion of S. epidermidis 1457 Δica and the Δica Δaap double mutant to corneocytes was tested. Incubating corneocytes with 100 μg/mL of SasG resulted in a significant decrease in adhesion of S. epidermidis Δica compared to the bovine serum albumin (BSA) control, demonstrating the ability of a protein homologous to Aap to block access of S. epidermidis to the host ligand (Fig. 4A). Incubating corneocytes with 100 μg/mL of SasG also resulted in a very slight decrease of adhesion of S. epidermidis Δica Δaap to corneocytes, but this decrease was not significantly different from the BSA control (Fig. 4A). Representative bright-field, green-channel, and bright-field/green-channel overlay images can be seen in Fig. 4B. These images were not taken with red autofluorescence of corneocytes via trypan blue due to an overall lower abundance of bacteria than in nonstained controls (data not shown).

FIG 4.

FIG 4

Blocking adhesion of S. epidermidis to corneocytes with SasG. (A) S. epidermidis 1457 Δica (AH2983) and S. epidermidis 1457 Δica Δaap (AH2984) were tested for adhesion to healthy human corneocytes after incubation/blocking with full-length SasG. Corneocytes were incubated with 300 μL BSA as a protein control. The percent area of adhesion in 10 images from three independent experiments (n = 30) was measured with Fiji ImageJ and analyzed in GraphPad Prism. Statistical significance was analyzed using one-way ANOVA. Statistical significance of all groups except for the Δica Δaap strain plus SasG are mapped to the Δica strain plus BSA (P < 0.0001). Statistical significance of the Δica Δaap strain plus SasG is mapped to the Δica Δaap strain plus BSA (P = 0.0447). (B) Representative bright-field, green-channel, and bright-field/green-channel overlay images of BSA and SasG experimental groups tested in the corneocyte adhesion assay.

SasG expression promotes S. carnosus adhesion to corneocytes.

S. carnosus is an avirulent and apathogenic CoNS lacking many virulence factors present in other species, such as S. epidermidis and S. aureus (34). We constructed strain AH5687 as a new tool to assess the function of bacterial surface proteins. To reduce any background binding, allelic replacement was used to inactivate genes with homology to S. aureus ClfB (SCA_2283) and protein A (SCA_2092), and we also inserted GFP into the SCA_2283 locus to aid microscopy visualization. As shown in Fig. 3, S. carnosus strain AH5687 does not adhere to human corneocytes naturally and therefore is an ideal host for heterologous expression of SasG or other surface proteins.

We hypothesized that expression of only SasG would enable attachment of S. carnosus to human corneocytes. As an expression vector, we used pALC2073, a known tetracycline-inducible plasmid with high background expression (35). We selected two strains that express full-length SasG, including MRSA strain COL and USA400 MRSA strain MW2. pALC2073-sasGMW2 was previously constructed (33), and we cloned pALC2073-sasGCOL and electroporated these plasmids into S. carnosus strain AH5687. S. carnosus containing just pALC2073 did not adhere to corneocytes (Fig. 5A), confirming the data shown in Fig. 3. However, S. carnosus containing either pALC2073-sasGCOL or pALC2073-sasGMW2 adhered strongly to corneocytes, indicating full-length SasG from both of these strains is fully capable of adhesion (Fig. 5A). Representative green-channel, red-channel, and red- and green-channel overlay images of each strain in this assay can be seen in Fig. 5B. For each pALC2073 plasmid construct, tetracycline induction was not necessary to obtain significant adhesion to corneocytes.

FIG 5.

FIG 5

SasG expression promotes S. carnosus adhesion to corneocytes. (A) pALC2073 empty vector (EV), full-length SasG-expressing strains AH5908 (pALC2073-sasGCOL) and AH5905 (pALC2073-sasGMW2), and AH6012 (pALC2073-sasGMW2ΔA) were tested for the ability to adhere to healthy human corneocytes. The percent area of adhesion in 10 images from three independent experiments (n = 30) was measured with Fiji ImageJ and analyzed in GraphPad Prism. Statistical significance was analyzed using the Kruskal-Wallis nonparametric test. Statistical significance of all groups except for pALC2073-sasGMW2ΔA is mapped to pALC2073 EV (P < 0.0001). Statistical significance of pALC2073-sasGMW2ΔA is mapped to pALC2073-sasGMW2 (P < 0.0001). (B) Representative green-channel, red-channel, and red- and green-channel overlay images of each species and strain tested in the corneocyte adhesion assay.

To expand on these findings, we tested the contribution of the SasG A domain to adherence. As shown by Roy et al. (25), the Aap A domain is important for adhesion to human skin corneocytes, and we reasoned that SasG-mediated adhesion would also be dependent upon the A domain. We therefore constructed pALC2073-sasGMW2ΔA, which encodes SasG lacking the A domain, and electroporated this plasmid into S. carnosus strain AH5687. S. carnosus containing pALC2073-sasGMW2ΔA did not adhere to corneocytes and exhibited adherence levels similar to those seen with pALC2073 EV (Fig. 5A). Microscopy imaging of these corneocytes confirmed this observation (Fig. 5B). To verify SasG expression, SDS-PAGE electrophoresis and Coomassie staining of proteins from the cell wall of S. carnosus strains AH5905 (pALC2073-sasGMW2), AH5907 (pAL2073 EV), AH5908 (pALC2073-sasGCOL), and AH6012 (pALC2073-sasGMW2ΔA) grown in liquid culture and solubilized by lysostaphin was conducted (Fig. S1). Strains were grown either with or without induction with 100 ng/mL anhydrotetracycline. SasG from strain MRSA MW2 was characterized previously to be ~230 kDa (36), with a predicted molecular mass of 150 kDa, while the predicted molecular mass of SasG from strain MRSA COL is similar to that of MRSA MW2 at 136 kDa. Coomassie staining verified the previously characterized molecular mass, with corresponding bands for AH5905 and AH5908 at ~230 kDa (Fig. S1). A band at ~230 kDa was missing from AH6012, with the next most prominent band at ~125 kDa, verifying a lower molecular mass corresponding to deletion of the SasG A domain from MRSA MW2 (Fig. S1). A band at ~230 kDa was also missing from AH5907, with the next most prominent band at ~75 kDa, verifying the lack of SasG expression on the EV plasmid. There were no differences in SasG expression between uninduced strains and those induced with anhydrotetracycline (Fig. S1). These findings indicate that multiple SasG variants are capable of and important for adherence to corneocytes, which is dependent upon the A domain. Finally, we demonstrated that our newly constructed S. carnosus strain, AH5687, is a useful tool for heterologous expression of bacterial surface proteins.

DISCUSSION

Corneocyte adhesion assays have been characterized in a wide variety of applications for studying bacterial adhesion to both human and animal corneocytes (25, 2730). However, in past studies, microscopy images of corneocytes have largely been limited to using only the brightfield channel, which reduces the clarity. While staphylococcal adhesion methods to human corneocytes have been developed (25), we endeavored to improve on this assay to better visualize the human host cells. Our new method allows superior images of corneocytes to be acquired via red autofluorescence with trypan blue, a dye that is commonly used for cell culture applications to stain dead cells. To the best of our knowledge, this method is the first to combine trypan blue staining with overlaying of green-channel images to study adhesion of staphylococci to corneocytes. Additionally, we engineered a new S. carnosus expression strain as a heterologous host to study staphylococcal adhesion to human corneocytes. As the skin is the largest organ of the human body and acts as an essential barrier against a wide array of pathogens, especially those of the genus Staphylococcus (7, 37), the optimized assay and tools described in this work are relevant to the study aspects of both microbial colonization and adhesion to healthy human skin.

This optimized method expanded on the importance of SasG to S. aureus adhesion to healthy human corneocytes. We confirmed the findings by Roy et al. (25) that loss of Aap abrogates S. epidermidis binding to corneocytes and mutation of MgrA increases SasG expression and subsequent MRSA MW2 adhesion to corneocytes. We demonstrated the ability of purified SasG to reduce adhesion to corneocytes of other staphylococci and showed that expressing full-length SasG from two MRSA strains in S. carnosus enabled a nonadherent staphylococcal strain to bind corneocytes. Roy et al. (25) identified the A domain as the portion of Aap specifically responsible for adhesion to the host ligand (likely a glycoprotein). Our results corroborated this in the homologous protein SasG, as S. carnosus expressing SasG with the A domain mutated did not adhere to corneocytes. As the host ligand is currently unknown, further studies elucidating SasG-mediated binding with the specific SC ligand are warranted upon its discovery. The importance of CWA proteins in adhesion suggests that using inhibitors of these binding interactions could be a promising therapeutic approach to prevent S. aureus skin colonization in individuals at risk for infection.

There are some limitations to this method in terms of quantification and qualitatively in terms of corneocyte staining. In this assay, quantification with Fiji ImageJ acquires the percent area of the entire image, even though corneocytes do not fill 100% of the image. However, there may be other ways in which to utilize ImageJ that may fill this gap. For the trypan blue staining, we were unable to acquire images that accurately represented bacterial adhesion after blocking with protein. It may be that incubation and subsequent washing for protein, bacteria, and staining caused bacteria to wash off after the final phosphate-buffered saline (PBS) wash. This assay can also result in nonnormal distribution, as demonstrated in Fig. 3A. Collecting corneocytes from the skin of different volunteers may contribute to this, as the thickness and distribution of the corneocytes can differ depending on the individual and skin condition. Despite these limitations, this method provides a useful way to study adhesion of staphylococci to corneocytes. This is especially beneficial for comparing trends of adhesion of different species and strains and/or with the use of S. carnosus as a model surrogate organism. This method has the potential to be used in studies with disease-state skin corneocytes (such as those from AD skin), nasal corneocytes, and animal corneocytes and with other fluorescently labeled microorganisms.

MATERIALS AND METHODS

Corneocyte collection.

Collection of corneocytes was optimized based on the method published by Roy et al. (25), with modifications. Healthy corneocytes were collected from either the lower or upper arm near the elbow from human volunteers. Skin that was not overly moist (had not been recently moisturized) and with little to no hair was chosen so that a more confluent layer of corneocytes could be collected (the condition of the skin may alter with the regional climate). Approximately six or seven discs can be applied to the upper or lower arm near the elbow at a time per volunteer to stay near the elbow. The selected area of skin was cleaned with an alcohol wipe and allowed to air dry. Clear, adhesive tape stripping discs (d-Squame D100; Clinical & Derm) were applied to the cleaned area (a different area of skin for each disc) and pressed firmly onto the skin for 30 s with a pressure device (d-Squame D500; Clinical & Derm) to ensure an even coating of cells on the disc. The discs with collected corneocytes were then carefully removed, taking care not to touch the clear adhesive area of the disc to prevent contamination and abrasion. Collection was considered successful if a thick coating of skin cells was perceptible. A sterile, empty pipette tip box and rack served as a moist chamber with a thin layer of tap water to maintain humidity. The discs with corneocytes were then placed adhesive side up on the empty tip box rack, and the lid was lightly closed to prevent possible settling of contaminants in the air onto the corneocytes. The corneocytes were used within an hour after collection and stored at ambient temperature in the tip box chamber until addition of bacterial/protein solutions.

Staphylococcal strains and plasmids.

Several species and strains of Staphylococcus were used in this study in order to compare adhesion of different MRSA strains and CoNS. The strains used in this study are listed in Table 1. All strains except the S. carnosus strains expressed GFP via maintenance of plasmid pCM29 with constitutively expressed superfolder green fluorescent protein (sGFP) (38). The plasmids were electroporated into recipient strains (39, 40).

To construct GFP-expressing S. carnosus strain AH5687 (a derivative of the strain TM300 [41]), homologs of S. aureus ClfB and protein A, which could potentially interfere with the adhesion assays, were mutated. SCA_2283, a homolog of S. aureus ClfB, was replaced with an expression construct of sGFP driven by a sarA P1 promoter. Fragments of 1,000 bp upstream and downstream of SCA_2238 were amplified with primer pairs JK131/JK132 and JK135/JK136 (primer sequences are provided in Table 2). sGFP was amplified from pCM29 (38) with primers JK133/JK134. The resulting fragments were cloned into pIMAY (42) using Gibson Assembly, producing pJK17. pJK17 was electroporated into S. carnosus TM300 using Escherichia coli DC10B (42) as an intermediate cloning host. Allelic replacement of SCA_2238 sGFP resulted in S. carnosus TM300 ΔSCA_2238::sGFP. Fragments of 1,000 bp upstream and downstream of SCA_2092, a gene encoding a homolog of S. aureus protein A, were amplified with primer pairs JK142/JK143 and JK144/JK145 and cloned into pIMAY using Gibson Assembly, producing pJK18. pJK18 was electroporated into S. carnosus TM300 ΔSCA_2238::sGFP, with E. coli DC10B used as an intermediate cloning host, and the gene was deleted using allelic exchange (42). Presence of desired mutations in both genes were confirmed via PCR, and the resulting strain, S. carnosus TM300 ΔSCA_2238::sGFP ΔSCA_2092, was named S. carnosus AH5687.

TABLE 2.

Oligonucleotides used in this study

Code Name Sequence
HC416 MW2 SasG 5′ KpnI 5′-GTTGGTACCCACTGTAAGTAAAGTGGAAAATATGGAA-3′
HC417 MW2 SasG 3′ SacI 5′-GTTGAGCTCTAGGTCTTTCAATCCAACTTTTGG-3′
HC527 MW2 SasG ΔA domain b-g-L-II_R 5′-GTCAGATCTAGCTGCTTCTGCCTCTTGTTGAG-3′
HC528 MW2 SasG ΔA domain b-g-L-II_F 5′-GTCAGATCTCTAACGCCTAATCTAGTTAATAAAACAGA-3′
JK131 SCA2283_upstream_F 5′-ACTAAAGGGAACAAAAGCTGGGTACGGCTTTTAATAAATCAAGATGC-3′
JK132 SCA2283_upstream_R 5′-CAAAAATATCAGAAAATCCCTCCTAAGATATAAAC-3′
JK133 Psar_sGFP_F 5′-TAGGAGGGATTTTCTGATATTTTTGACTAAACCAAATGC-3′
JK134 Psar_sGFP_R 5′-TATTTAAATGATTTTAGTGGTGGTGGTGGTG-3′
JK135 SCA2283_downstream_F 5′-CACCACCACTAAAATCATTTAAATAGAGGGCTG-3′
JK136 SCA2283_downstream_R 5′-ACTCACTATAGGGCGAATTGGAGCTGGTTTAATTTGCAGATATTCAC-3′
JK142 SCA2092_upstream_F 5′-ACTAAAGGGAACAAAAGCTGGGTACCGATACTATGTATAAAGTAATTGTATTTGATG-3′
JK143 SCA2092_upstream_R 5′-AATAAGTTTGTAGATGTGAAATCCTCCTATTG-3′
JK144 SCA2092_downstream_F 5′-AGGATTTCACATCTACAAACTTATTCTACTCTTACC-3′
JK145 SCA2092_downstream_R 5′-ACTCACTATAGGGCGAATTGGAGCTCACAATTTGGGTTTATGCAATTATTTATTTC-3′
KM22 COL SasG 3′ SacI 5′-GTTGAGCTCGAATGCATCCACCAGCTTTT-3′

SasG-expressing S. carnosus strains were generated by electroporation of tetracycline-inducible plasmid pALC2073 encoding SasG driven by the TetR-controlled Pxyl/tetO promoter into AH5687 (43, 44). An empty vector (EV) strain containing pALC2073 was electroporated into AH5687, resulting in strain AH5907. To construct AH5905, 1,000-bp fragments upstream and downstream of SasG from MRSA MW2 (a USA400 strain) were amplified using primers HC416/HC417 (Table 2), cloned into pALC2073 using restriction cloning, and then electroporated into AH5687. This resulted in plasmid pALC2073-sasGMW2, which promotes expression of full-length SasG from MRSA MW2 in AH5687. To construct AH5908, 1,000-bp fragments upstream and downstream of SasG from MRSA COL were amplified using primers HC416/KM22, cloned into pALC2073 using restriction cloning, and then electroporated into AH5687. This resulted in plasmid pALC2073-sasGCOL, which promotes expression of full-length SasG from MRSA COL in AH5687. To construct AH6012, the entirety of pALC2073-sasGMW2 except for the A domain region of SasG was amplified using primers HC527/HC528, each containing a b-g-L-II sequence. The resulting plasmid pHC109 (pALC2073-sasGMW2ΔA) was electroporated into AH5687 and lacks the portion of the protein considered responsible for adhesion to corneocytes in SasG from MRSA MW2. The plasmids were confirmed via PCR.

Preparation of bacterial cultures.

All strains except S. carnosus were grown in tryptic soy broth (TSB; Research Products International) with 10 μg/mL of chloramphenicol to maintain the plasmid (25). S. carnosus was grown in TSB without antibiotic. Five milliliters of bacterial cultures was grown in Pyrex Vista rimless 15-mL round-bottom reusable glass culture tubes (Fisher Scientific) at 37°C overnight with shaking aeration at 220 rpm. Overnight cultures were then subcultured 1:50 in 3 mL of TSB with antibiotic (if applicable) and grown to an optical density at 600 nm (OD600) of approximately 0.75 at 37°C with shaking aeration. OD was measured using the Genesys 30 VIS spectrophotometer (Thermo Scientific). Cultures were spun down at room temperature for 3 min at 8,000 × g using an accuSpin Micro 17 tabletop centrifuge (Fisher Scientific). Cultures were then resuspended in an equal volume of sterile PBS and diluted in PBS to an OD600 of 0.15 (~107 CFU/mL) (25). Using this OD results in adhesion of a sufficient number of cells to allow easy enumeration without causing unwanted bacterial clumping (25).

Preparation of protein solution for adhesion inhibition.

To observe inhibition of adhesion with protein in solution, a BSA control and full-length S. aureus surface protein G (SasG) protein solutions were prepared. BSA was suspended in PBS at a final concentration of 100 μg/mL and filtered using a 0.22-μm syringe filter. Previously characterized, full-length recombinant SasG (purified from MRSA MW2; 250 kDa) was added to PBS at a final concentration of 100 μg/mL (33). The concentration of 100 μg/mL was chosen because it causes significant reduction in adhesion in a dose-response assay (data not shown).

Incubation (bacteria only).

After collection of corneocytes, 300 μL (~3.3 × 106 CFU total) of prepared staphylococcal suspensions in PBS were individually pipetted slowly as a droplet onto the center of one corresponding disc. The lid was then lightly closed to prevent settling of contaminants in the air onto the discs. The box with the corneocytes was then placed into a humidified 37°C incubator with 5% CO2, taking care not to jostle the droplets. The suspension droplets were incubated on the corneocytes for 45 min (25) and prepared for imaging as described in “Corneocyte staining for autofluorescence” and “Imaging.”

Incubation (inhibition of adhesion with protein followed by bacteria).

Three hundred microliters of prepared BSA or full-length SasG were individually added onto the corneocytes and incubated for 45 min. Corneocytes were then washed and allowed to air dry as described in “Imaging.” Prepared bacterial cultures were then added to the dried corneocytes on the same spot that the protein solution was added to, incubated for 45 min as described in “Incubation (bacteria only),” and then prepared for imaging as described in “Imaging.”

Corneocyte staining for autofluorescence.

In order to visualize corneocytes fluorescently, trypan blue solution (0.4%; Gibco) was added to corneocytes after addition of bacteria to allow red autofluorescence of the corneocytes. After incubation and washing off the bacteria, corneocytes were allowed to air dry. Three hundred microliters of trypan blue was then added to the dried corneocytes on the area where the bacteria were added and incubated at room temperature for 15 min. The corneocytes were then gently washed twice with 1 mL PBS as described in “Imaging.” The backs of the discs were washed once with 1 mL PBS. Trypan blue was not added to corneocytes if protein was added.

Imaging.

After incubation and staining, microscope slides (plain glass; 1-mm thickness, 3 by 1 in.; Fisher Scientific) were cleaned with 70% ethanol sprayed on a Kimwipe and allowed to air dry. The corneocytes were washed 10 times with 1 mL PBS. The disc was turned over and washed on the nonadhesive side twice with 1 mL PBS to remove any possible backsplash on the nonadhesive side of the disc. The backs of the discs were blotted gently with a Kimwipe to remove moisture and then placed on one cleaned slide for each disc. The corneocytes were left to air dry on the slides. Once completely dry, a drop of aqueous mounting medium (Glycergel; Agilent Technologies) was placed in the center of each disc. A rectangular coverslip (thickness, 0.14 mm; 22 by 50 mm; Globe Scientific) was then immediately placed onto the disc. The coverslip was secured onto the slide with clear scotch tape. The slides were then stored at 4°C overnight in order for the mounting medium to have adequate time to dry.

The corneocytes were imaged using a Keyence BZ-X 710 fluorescence microscope at ×20 magnification using the bright-field, red, and green channels. Ten images were taken of each disc; each area was marked in the imaging software so as to avoid duplicate images. Overlay images of bright-field and green channels and green and red channels were acquired. The bright-field channel imaged corneocytes only without fluorescence, the green channel imaged green-fluorescent bacteria, the red channel imaged corneocytes with red autofluorescence. Images were not acquired in any areas where there may have been bacterial clumping or disproportionate binding to areas between corneocytes.

Data and statistical analysis.

Images captured with the green channel were quantified for percent area of adhesion using Fiji ImageJ (45). Images were converted to 8-bit images and adjusted to the Otsu threshold. Once the images were adjusted, the “analyze>measure” prompt in ImageJ was selected to acquire “percent area.” Ten images for each disc/experimental group were statistically analyzed with either one-way analysis of variance (ANOVA) or the nonparametric Kruskal-Wallis equivalent in GraphPad Prism. Ten data points from three independent experiments (n = 30) were analyzed for final results in GraphPad Prism. A schematic of the corneocyte adhesion method is shown in Fig. 1.

ACKNOWLEDGMENT

This work was funded by NIH/NIAID grant AI162964 to P.D.F. and A.R.H.

Footnotes

Supplemental material is available online only.

Supplemental file 1
Fig. S1. Download spectrum.02469-22-s0001.pdf, PDF file, 0.4 MB (392.9KB, pdf)

Contributor Information

Alexander R. Horswill, Email: alexander.horswill@cuanschutz.edu.

Catherine Ayn Brissette, University of North Dakota.

REFERENCES

  • 1.Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S. 2018. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4:18033. doi: 10.1038/nrdp.2018.33. [DOI] [PubMed] [Google Scholar]
  • 2.O'Gara JP. 2017. Into the storm: chasing the opportunistic pathogen Staphylococcus aureus from skin colonisation to life-threatening infections. Environ Microbiol 19:3823–3833. doi: 10.1111/1462-2920.13833. [DOI] [PubMed] [Google Scholar]
  • 3.Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA, EMERGEncy ID Net Study Group . 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674. doi: 10.1056/NEJMoa055356. [DOI] [PubMed] [Google Scholar]
  • 4.Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr.. 2015. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28:603–661. doi: 10.1128/CMR.00134-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.da Costa TM, Viljoen A, Towell AM, Dufrene YF, Geoghegan JA. 2022. Fibronectin binding protein B binds to loricrin and promotes corneocyte adhesion by Staphylococcus aureus. Nat Commun 13:2517. doi: 10.1038/s41467-022-30271-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sakr A, Bregeon F, Mege JL, Rolain JM, Blin O. 2018. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Front Microbiol 9:2419. doi: 10.3389/fmicb.2018.02419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brown MM, Kwiecinski JM, Cruz LM, Shahbandi A, Todd DA, Cech NB, Horswill AR. 2020. Novel peptide from commensal Staphylococcus simulans blocks methicillin-resistant Staphylococcus aureus quorum sensing and protects host skin from damage. Antimicrob Agents Chemother 64:e00172-20. doi: 10.1128/AAC.00172-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jenkins A, Diep BA, Mai TT, Vo NH, Warrener P, Suzich J, Stover CK, Sellman BR. 2015. Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease. mBio 6:e02272-14. doi: 10.1128/mBio.02272-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sollid JU, Furberg AS, Hanssen AM, Johannessen M. 2014. Staphylococcus aureus: determinants of human carriage. Infect Genet Evol 21:531–541. doi: 10.1016/j.meegid.2013.03.020. [DOI] [PubMed] [Google Scholar]
  • 10.Kullander J, Forslund O, Dillner J. 2009. Staphylococcus aureus and squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 18:472–478. doi: 10.1158/1055-9965.EPI-08-0905. [DOI] [PubMed] [Google Scholar]
  • 11.Williams MR, Costa SK, Zaramela LS, Khalil S, Todd DA, Winter HL, Sanford JA, O'Neill AM, Liggins MC, Nakatsuji T, Cech NB, Cheung AL, Zengler K, Horswill AR, Gallo RL. 2019. Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis. Sci Transl Med 11:eaat8329. doi: 10.1126/scitranslmed.aat8329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, Salem SS, Brinton SL, Rudman Spergel AK, Johnson K, Jepson B, Calatroni A, David G, Ramirez-Gama M, Taylor P, Leung DYM, Gallo RL. 2021. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med 27:700–709. doi: 10.1038/s41591-021-01256-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Nakatsuji T, Gallo RL, Shafiq F, Tong Y, Chun K, Butcher AM, Cheng JY, Hata TR. 2021. Use of autologous bacteriotherapy to treat Staphylococcus aureus in patients with atopic dermatitis: a randomized double-blind clinical trial. JAMA Dermatol 157:978. doi: 10.1001/jamadermatol.2021.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nakatsuji T, Cheng JY, Gallo RL. 2021. Mechanisms for control of skin immune function by the microbiome. Curr Opin Immunol 72:324–330. doi: 10.1016/j.coi.2021.09.001. [DOI] [PubMed] [Google Scholar]
  • 15.Wertz PW, de Szalay S. 2020. Innate antimicrobial defense of skin and oral mucosa. Antibiotics (Basel) 9:159. doi: 10.3390/antibiotics9040159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tzani-Tzanopoulou P, Skliros D, Megremis S, Xepapadaki P, Andreakos E, Chanishvili N, Flemetakis E, Kaltsas G, Taka S, Lebessi E, Doudoulakakis A, Papadopoulos NG. 2020. Interactions of bacteriophages and bacteria at the airway mucosa: new insights into the pathophysiology of asthma. Front Allergy 1:617240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.von Eiff C, Becker K, Machka K, Stammer H, Peters G. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344:11–16. doi: 10.1056/NEJM200101043440102. [DOI] [PubMed] [Google Scholar]
  • 18.Eyerich S, Eyerich K, Traidl-Hoffmann C, Biedermann T. 2018. Cutaneous barriers and skin immunity: differentiating a connected network. Trends Immunol 39:315–327. doi: 10.1016/j.it.2018.02.004. [DOI] [PubMed] [Google Scholar]
  • 19.Wong R, Geyer S, Weninger W, Guimberteau JC, Wong JK. 2016. The dynamic anatomy and patterning of skin. Exp Dermatol 25:92–98. doi: 10.1111/exd.12832. [DOI] [PubMed] [Google Scholar]
  • 20.Foster TJ, Geoghegan JA, Ganesh VK, Hook M. 2014. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol 12:49–62. doi: 10.1038/nrmicro3161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mulcahy ME, Geoghegan JA, Monk IR, O'Keeffe KM, Walsh EJ, Foster TJ, McLoughlin RM. 2012. Nasal colonisation by Staphylococcus aureus depends upon clumping factor B binding to the squamous epithelial cell envelope protein loricrin. PLoS Pathog 8:e1003092. doi: 10.1371/journal.ppat.1003092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fleury OM, McAleer MA, Feuillie C, Formosa-Dague C, Sansevere E, Bennett DE, Towell AM, McLean WHI, Kezic S, Robinson DA, Fallon PG, Foster TJ, Dufrene YF, Irvine AD, Geoghegan JA. 2017. Clumping factor B promotes adherence of Staphylococcus aureus to corneocytes in atopic dermatitis. Infect Immun 85:e00994-16. doi: 10.1128/IAI.00994-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Macintosh RL, Brittan JL, Bhattacharya R, Jenkinson HF, Derrick J, Upton M, Handley PS. 2009. The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes. J Bacteriol 191:7007–7016. doi: 10.1128/JB.00764-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Corrigan RM, Rigby D, Handley P, Foster TJ. 2007. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology (Reading) 153:2435–2446. doi: 10.1099/mic.0.2007/006676-0. [DOI] [PubMed] [Google Scholar]
  • 25.Roy P, Horswill AR, Fey PD. 2021. Glycan-dependent corneocyte adherence of Staphylococcus epidermidis mediated by the lectin subdomain of Aap. mBio 12:e02908-20. doi: 10.1128/mBio.02908-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Roche FM, Meehan M, Foster TJ. 2003. The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology (Reading) 149:2759–2767. doi: 10.1099/mic.0.26412-0. [DOI] [PubMed] [Google Scholar]
  • 27.Simou C, Hill PB, Forsythe PJ, Thoday KL. 2005. Species specificity in the adherence of staphylococci to canine and human corneocytes: a preliminary study. Vet Dermatol 16:156–161. doi: 10.1111/j.1365-3164.2005.00452.x. [DOI] [PubMed] [Google Scholar]
  • 28.Griffeth GC, Callori N, Rankin SC, Boston RC, Morris DO. 2012. Optimization of a Staphylococcus aureus adhesion assay for equine corneocytes. Vet Dermatol 23:57–60, e13. doi: 10.1111/j.1365-3164.2011.01012.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Latronico F, Moodley A, Nielsen SS, Guardabassi L. 2014. Enhanced adherence of methicillin-resistant Staphylococcus pseudintermedius sequence type 71 to canine and human corneocytes. Vet Res 45:70. doi: 10.1186/1297-9716-45-70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lu YF, McEwan NA. 2007. Staphylococcal and micrococcal adherence to canine and feline corneocytes: quantification using a simple adhesion assay. Vet Dermatol 18:29–35. doi: 10.1111/j.1365-3164.2007.00567.x. [DOI] [PubMed] [Google Scholar]
  • 31.Parlet CP, Brown MM, Horswill AR. 2019. Commensal staphylococci influence Staphylococcus aureus skin colonization and disease. Trends Microbiol 27:497–507. doi: 10.1016/j.tim.2019.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rosenstein R, Gotz F. 2010. Genomic differences between the food-grade Staphylococcus carnosus and pathogenic staphylococcal species. Int J Med Microbiol 300:104–108. doi: 10.1016/j.ijmm.2009.08.014. [DOI] [PubMed] [Google Scholar]
  • 33.Kwiecinski JM, Crosby HA, Valotteau C, Hippensteel JA, Nayak MK, Chauhan AK, Schmidt EP, Dufrene YF, Horswill AR. 2019. Staphylococcus aureus adhesion in endovascular infections is controlled by the ArlRS-MgrA signaling cascade. PLoS Pathog 15:e1007800. doi: 10.1371/journal.ppat.1007800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lofblom J, Rosenstein R, Nguyen MT, Stahl S, Gotz F. 2017. Staphylococcus carnosus: from starter culture to protein engineering platform. Appl Microbiol Biotechnol 101:8293–8307. doi: 10.1007/s00253-017-8528-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Palma M, Cheung AL. 2001. σB activity in Staphylococcus aureus is controlled by RsbU and an additional factor(s) during bacterial growth. Infect Immun 69:7858–7865. doi: 10.1128/IAI.69.12.7858-7865.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Crosby HA, Schlievert PM, Merriman JA, King JM, Salgado-Pabon W, Horswill AR. 2016. The Staphylococcus aureus global regulator MgrA modulates clumping and virulence by controlling surface protein expression. PLoS Pathog 12:e1005604. doi: 10.1371/journal.ppat.1005604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Uberoi A, Bartow-McKenney C, Zheng Q, Flowers L, Campbell A, Knight SAB, Chan N, Wei M, Lovins V, Bugayev J, Horwinski J, Bradley C, Meyer J, Crumrine D, Sutter CH, Elias P, Mauldin E, Sutter TR, Grice EA. 2021. Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor. Cell Host Microbe 29:1235–1248.E8. doi: 10.1016/j.chom.2021.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Pang YY, Schwartz J, Thoendel M, Ackermann LW, Horswill AR, Nauseef WM. 2010. agr-dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun 2:546–559. doi: 10.1159/000319855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Schneewind O, Missiakas D. 2014. Genetic manipulation of Staphylococcus aureus. Curr Protoc Microbiol 32:Unit 9C 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lofblom J, Kronqvist N, Uhlen M, Stahl S, Wernerus H. 2007. Optimization of electroporation-mediated transformation: Staphylococcus carnosus as model organism. J Appl Microbiol 102:736–747. doi: 10.1111/j.1365-2672.2006.03127.x. [DOI] [PubMed] [Google Scholar]
  • 41.Rosenstein R, Nerz C, Biswas L, Resch A, Raddatz G, Schuster SC, Gotz F. 2009. Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol 75:811–822. doi: 10.1128/AEM.01982-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Monk IR, Shah IM, Xu M, Tan MW, Foster TJ. 2012. Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. mBio 3:e00277-11. doi: 10.1128/mBio.00277-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bateman BT, Donegan NP, Jarry TM, Palma M, Cheung AL. 2001. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect Immun 69:7851–7857. doi: 10.1128/IAI.69.12.7851-7857.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Corrigan RM, Foster TJ. 2009. An improved tetracycline-inducible expression vector for Staphylococcus aureus. Plasmid 61:126–129. doi: 10.1016/j.plasmid.2008.10.001. [DOI] [PubMed] [Google Scholar]
  • 45.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental file 1

Fig. S1. Download spectrum.02469-22-s0001.pdf, PDF file, 0.4 MB (392.9KB, pdf)


Articles from Microbiology Spectrum are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES